gliclazide has been researched along with Kidney Failure, Chronic in 7 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raslan, IA | 1 |
| McDonald, EG | 1 |
| Lee, TC | 1 |
| Lee, YH | 1 |
| Lee, CJ | 1 |
| Lee, HS | 1 |
| Choe, EY | 1 |
| Lee, BW | 1 |
| Ahn, CW | 1 |
| Cha, BS | 1 |
| Lee, HC | 1 |
| Balkau, B | 1 |
| Kang, ES | 1 |
| Oei, E | 1 |
| Samad, N | 1 |
| Visser, A | 1 |
| Chowdhury, TA | 1 |
| Fan, SL | 1 |
| Wong, MG | 1 |
| Perkovic, V | 1 |
| Chalmers, J | 2 |
| Woodward, M | 2 |
| Li, Q | 2 |
| Cooper, ME | 1 |
| Hamet, P | 1 |
| Harrap, S | 2 |
| Heller, S | 1 |
| MacMahon, S | 1 |
| Mancia, G | 1 |
| Marre, M | 2 |
| Matthews, D | 1 |
| Neal, B | 1 |
| Poulter, N | 1 |
| Rodgers, A | 1 |
| Williams, B | 1 |
| Zoungas, S | 2 |
| Mohammedi, K | 1 |
| Patel, A | 1 |
| Shestakova, MV | 1 |
| De Vigan, C | 1 |
| Delporte, MP | 1 |
| Thomas, M | 1 |
| Perrault, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study[NCT00949286] | 8,494 participants (Actual) | Observational | 2010-01-31 | Completed | |||
| ADVANCE - Action in Diabetes and Vascular Disease: Preterax and Diamicron - MR Controlled Evaluation[NCT00145925] | Phase 3 | 11,140 participants (Actual) | Interventional | 2001-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for gliclazide and Kidney Failure, Chronic
| Article | Year |
|---|---|
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON.
Topics: Aged; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Drug Combin | 2016 |
Absence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 Diabetes.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diagnostic Techniques, Cardiovascular; Disea | 2016 |
5 other studies available for gliclazide and Kidney Failure, Chronic
| Article | Year |
|---|---|
Missed Opportunities for Deprescription: A Teachable Moment.
Topics: Aged, 80 and over; Deprescriptions; Diabetes Complications; Diabetes Mellitus; Drug Therapy, Combina | 2017 |
Comparing kidney outcomes in type 2 diabetes treated with different sulphonylureas in real-life clinical practice.
Topics: Cohort Studies; Creatinine; Diabetes Mellitus, Type 2; Female; Gliclazide; Humans; Hypoglycemic Agen | 2015 |
Use of continuous glucose monitoring in patients with diabetes on peritoneal dialysis: poor correlation with HbA1c and high incidence of hypoglycaemia.
Topics: Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; | 2016 |
[Diabetes mellitus and chronic kideny disease: modern diagnostics and treatment].
Topics: Albuminuria; Blood Glucose; Diabetic Nephropathies; Early Medical Intervention; Gliclazide; Glomerul | 2012 |
[Hypoglycemic complications of oral drug therapy of diabetes mellitus. 21 cases].
Topics: Age Factors; Aged; Diabetes Mellitus; Diabetic Coma; Drug Interactions; Female; Gliclazide; Glyburid | 1976 |